A prospective study by Lan et al., analyzing samples from 1227 stage I–III CRC patients post-resection, indicated that APC, BRAF and NRAS mutations were present in patients with earlier recurrence and worse outcomes [20]. This evidence concerns the gene NRAS and colorectal carcinoma.